We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

1azx

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1azx.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1azx.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1azx| PDB=1azx | SCENE= }}
{{STRUCTURE_1azx| PDB=1azx | SCENE= }}
-
'''ANTITHROMBIN/PENTASACCHARIDE COMPLEX'''
+
===ANTITHROMBIN/PENTASACCHARIDE COMPLEX===
-
==Overview==
+
<!--
-
Antithrombin, a plasma serpin, is relatively inactive as an inhibitor of the coagulation proteases until it binds to the heparan side chains that line the microvasculature. The binding specifically occurs to a core pentasaccharide present both in the heparans and in their therapeutic derivative heparin. The accompanying conformational change of antithrombin is revealed in a 2.9-A structure of a dimer of latent and active antithrombins, each in complex with the high-affinity pentasaccharide. Inhibitory activation results from a shift in the main sheet of the molecule from a partially six-stranded to a five-stranded form, with extrusion of the reactive center loop to give a more exposed orientation. There is a tilting and elongation of helix D with the formation of a 2-turn helix P between the C and D helices. Concomitant conformational changes at the heparin binding site explain both the initial tight binding of antithrombin to the heparans and the subsequent release of the antithrombin-protease complex into the circulation. The pentasaccharide binds by hydrogen bonding of its sulfates and carboxylates to Arg-129 and Lys-125 in the D-helix, to Arg-46 and Arg-47 in the A-helix, to Lys-114 and Glu-113 in the P-helix, and to Lys-11 and Arg-13 in a cleft formed by the amino terminus. This clear definition of the binding site will provide a structural basis for developing heparin analogues that are more specific toward their intended target antithrombin and therefore less likely to exhibit side effects.
+
The line below this paragraph, {{ABSTRACT_PUBMED_9405673}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 9405673 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_9405673}}
==About this Structure==
==About this Structure==
Line 32: Line 36:
[[Category: Serine protease inhibitor]]
[[Category: Serine protease inhibitor]]
[[Category: Serpin]]
[[Category: Serpin]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 10:53:41 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 17:56:24 2008''

Revision as of 14:56, 30 June 2008

Image:1azx.png

Template:STRUCTURE 1azx

ANTITHROMBIN/PENTASACCHARIDE COMPLEX

Template:ABSTRACT PUBMED 9405673

About this Structure

1AZX is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

The anticoagulant activation of antithrombin by heparin., Jin L, Abrahams JP, Skinner R, Petitou M, Pike RN, Carrell RW, Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14683-8. PMID:9405673

Page seeded by OCA on Mon Jun 30 17:56:24 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1azx"
Personal tools